Open AccessThe Na+/H+ exchanger (NHE1) is an essntial component of the EGFR pathway in pancreatic ductual adenocarcinoma (PDAC) and is a new target for combination therapy
Author(s) -
Rosa Angela Cardone,
Maria Raffaella Greco,
Katrine Zeeberg,
Angela Zaccagnino,
M Saccomano,
Massimo Menga,
Fatima Regina Abreu Alves,
Holger Kalthoff,
Valeria Casavola,
Reshkin Stephan
Publication year - 2014
Publication title -
frontiers in pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.384
H-Index - 86
ISSN - 1663-9812
DOI - 10.3389/conf.fphar.2014.61.00012
Subject(s) - cancer research , pancreatic cancer , tumor microenvironment , extracellular , gemcitabine , metastasis , hypoxia (environmental) , medicine , chemistry , cancer , biology , microbiology and biotechnology , tumor cells , organic chemistry , oxygen